SCYX
Price
$0.73
Change
+$0.01 (+1.39%)
Updated
Jul 3 closing price
Capitalization
55.88M
45 days until earnings call
TLRY
Price
$0.54
Change
+$0.05 (+10.20%)
Updated
Jul 3 closing price
Capitalization
1.87B
19 days until earnings call
Interact to see
Advertisement

SCYX vs TLRY

Header iconSCYX vs TLRY Comparison
Open Charts SCYX vs TLRYBanner chart's image
SCYNEXIS
Price$0.73
Change+$0.01 (+1.39%)
Volume$70.95K
Capitalization55.88M
Tilray Brands
Price$0.54
Change+$0.05 (+10.20%)
Volume$43.04M
Capitalization1.87B
SCYX vs TLRY Comparison Chart in %
Loading...
SCYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TLRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SCYX vs. TLRY commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SCYX is a StrongBuy and TLRY is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2025
Stock price -- (SCYX: $0.73 vs. TLRY: $0.54)
Brand notoriety: SCYX: Not notable vs. TLRY: Notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: SCYX: 58% vs. TLRY: 169%
Market capitalization -- SCYX: $55.88M vs. TLRY: $1.87B
SCYX [@Pharmaceuticals: Other] is valued at $55.88M. TLRY’s [@Pharmaceuticals: Other] market capitalization is $1.87B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.8B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SCYX’s FA Score shows that 0 FA rating(s) are green whileTLRY’s FA Score has 0 green FA rating(s).

  • SCYX’s FA Score: 0 green, 5 red.
  • TLRY’s FA Score: 0 green, 5 red.
According to our system of comparison, TLRY is a better buy in the long-term than SCYX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SCYX’s TA Score shows that 4 TA indicator(s) are bullish while TLRY’s TA Score has 4 bullish TA indicator(s).

  • SCYX’s TA Score: 4 bullish, 5 bearish.
  • TLRY’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both SCYX and TLRY are a bad buy in the short-term.

Price Growth

SCYX (@Pharmaceuticals: Other) experienced а -0.69% price change this week, while TLRY (@Pharmaceuticals: Other) price change was +30.63% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.13%. For the same industry, the average monthly price growth was +3.08%, and the average quarterly price growth was +93.03%.

Reported Earning Dates

SCYX is expected to report earnings on Aug 18, 2025.

TLRY is expected to report earnings on Oct 02, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+2.13% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TLRY($1.87B) has a higher market cap than SCYX($55.9M). TLRY has higher P/E ratio than SCYX: TLRY (8.52) vs SCYX (1.06). SCYX YTD gains are higher at: -39.554 vs. TLRY (-59.496). SCYX has higher annual earnings (EBITDA): 70.9M vs. TLRY (-1.23B). TLRY has more cash in the bank: 260M vs. SCYX (74.4M). SCYX has less debt than TLRY: SCYX (15.1M) vs TLRY (529M). TLRY has higher revenues than SCYX: TLRY (700M) vs SCYX (140M).
SCYXTLRYSCYX / TLRY
Capitalization55.9M1.87B3%
EBITDA70.9M-1.23B-6%
Gain YTD-39.554-59.49666%
P/E Ratio1.068.5213%
Revenue140M700M20%
Total Cash74.4M260M29%
Total Debt15.1M529M3%
FUNDAMENTALS RATINGS
SCYX vs TLRY: Fundamental Ratings
SCYX
TLRY
OUTLOOK RATING
1..100
5312
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
48
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9696
PRICE GROWTH RATING
1..100
9265
P/E GROWTH RATING
1..100
9995
SEASONALITY SCORE
1..100
3685

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TLRY's Valuation (48) in the Biotechnology industry is in the same range as SCYX (54) in the Pharmaceuticals Other industry. This means that TLRY’s stock grew similarly to SCYX’s over the last 12 months.

TLRY's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as SCYX (100) in the Pharmaceuticals Other industry. This means that TLRY’s stock grew similarly to SCYX’s over the last 12 months.

TLRY's SMR Rating (96) in the Biotechnology industry is in the same range as SCYX (96) in the Pharmaceuticals Other industry. This means that TLRY’s stock grew similarly to SCYX’s over the last 12 months.

TLRY's Price Growth Rating (65) in the Biotechnology industry is in the same range as SCYX (92) in the Pharmaceuticals Other industry. This means that TLRY’s stock grew similarly to SCYX’s over the last 12 months.

TLRY's P/E Growth Rating (95) in the Biotechnology industry is in the same range as SCYX (99) in the Pharmaceuticals Other industry. This means that TLRY’s stock grew similarly to SCYX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SCYXTLRY
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
81%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 12 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
SCYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TLRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AUENX21.640.16
+0.74%
AQR Large Cap Defensive Style N
FTHNX45.64N/A
N/A
FullerThaler Behavioral Sm-Cp Eq Inv
IVPSX12.77N/A
N/A
Voya Small Company Port S
BEMCX10.06N/A
N/A
Brandes Emerging Markets Value C
JESSX17.56N/A
N/A
Janus Henderson Global Sust Eq S

SCYX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SCYX has been loosely correlated with AQST. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if SCYX jumps, then AQST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCYX
1D Price
Change %
SCYX100%
+1.57%
AQST - SCYX
36%
Loosely correlated
+1.09%
CRON - SCYX
30%
Poorly correlated
+2.00%
AKAN - SCYX
30%
Poorly correlated
+5.38%
TLRY - SCYX
29%
Poorly correlated
+11.03%
ACB - SCYX
29%
Poorly correlated
+1.57%
More

TLRY and

Correlation & Price change

A.I.dvisor indicates that over the last year, TLRY has been closely correlated with SNDL. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if TLRY jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TLRY
1D Price
Change %
TLRY100%
+11.03%
SNDL - TLRY
76%
Closely correlated
+1.60%
CGC - TLRY
63%
Loosely correlated
+7.56%
OGI - TLRY
61%
Loosely correlated
+3.62%
CRON - TLRY
61%
Loosely correlated
+2.00%
ACB - TLRY
56%
Loosely correlated
+1.57%
More